| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 82.15B | 80.12B | 93.69B | 115.66B | 77.36B | 60.94B |
| Gross Profit | 20.37B | 22.64B | 30.87B | 8.16B | 45.00M | 14.52B |
| EBITDA | 10.85B | 13.83B | 6.00B | 7.00B | 11.09B | 7.42B |
| Net Income | 3.15B | 4.53B | 517.00M | 1.83B | 4.69B | 1.02B |
Balance Sheet | ||||||
| Total Assets | 109.44B | 111.36B | 113.51B | 134.01B | 119.76B | 95.39B |
| Cash, Cash Equivalents and Short-Term Investments | 3.24B | 7.03B | 6.96B | 8.92B | 5.23B | 3.78B |
| Total Debt | 39.54B | 39.06B | 35.44B | 34.15B | 34.66B | 32.84B |
| Total Liabilities | 85.62B | 87.19B | 93.54B | 112.14B | 101.87B | 86.33B |
| Stockholders Equity | 17.43B | 17.84B | 14.11B | 15.92B | 12.05B | 4.92B |
Cash Flow | ||||||
| Free Cash Flow | -1.04B | -1.30B | -356.00M | 5.47B | -418.00M | 951.00M |
| Operating Cash Flow | 6.20B | 5.67B | 5.65B | 10.04B | 4.07B | 5.31B |
| Investing Cash Flow | -6.82B | -6.63B | -5.59B | -3.15B | -5.40B | -1.86B |
| Financing Cash Flow | -663.00M | 1.11B | -1.84B | -3.15B | 2.26B | -2.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | €2.06B | 13.43 | 7.01% | 3.99% | -11.39% | -4.89% | |
69 Neutral | €31.58B | 12.14 | 7.90% | 2.58% | -7.36% | -25.03% | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
60 Neutral | €41.44B | 13.16 | 18.90% | 3.40% | 1.60% | 76.73% | |
58 Neutral | €21.92B | 52.39 | 3.57% | 2.25% | -10.30% | 0.96% |